132 related articles for article (PubMed ID: 11437061)
1. Effects of oxidative stress on the erythrocyte Na+,K+ ATPase activity in female hyperthyroid patients.
Konukoglu D; Yelke HK; Hatemi H; Sabuncu T
J Toxicol Environ Health A; 2001 Jun; 63(4):289-95. PubMed ID: 11437061
[TBL] [Abstract][Full Text] [Related]
2. Alteration of erythrocyte membrane Na, K-ATPase in children with borderline or essential hypertension.
Stojadinovic ND; Petronijević MR; Pavićević MH; Mrsulja BB; Kostić MM
Cell Biochem Funct; 1996 Jun; 14(2):79-87. PubMed ID: 8640956
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
4. Effects of ozone on the activity of erythrocyte membrane Na(+)-K+ ATPase.
Tükel SS; Bilgin R; Gül S
Biochem Mol Biol Int; 1994 Aug; 33(6):1033-40. PubMed ID: 7804127
[TBL] [Abstract][Full Text] [Related]
5. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
Raccah D; Lamotte-Jannot MF; Issautier T; Vague P
Diabete Metab; 1994; 20(3):271-4. PubMed ID: 8001715
[TBL] [Abstract][Full Text] [Related]
6. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
Canestrari F; Galli F; Gheller G; De Crescentini S; Biagiarelli B
Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
[TBL] [Abstract][Full Text] [Related]
7. Effects of fasting, refeeding, and fasting with T3 administration on Na-K,ATPase in rat skeletal muscle.
Matsumura M; Kuzuya N; Kawakami Y; Yamashita K
Metabolism; 1992 Sep; 41(9):995-9. PubMed ID: 1325595
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sodium/potassium adenosine triphosphatase in thyroid disease and nonthyroidal illness.
Dasmahapatra A; Cohen MP; Grossman SD; Lasker N
J Clin Endocrinol Metab; 1985 Jul; 61(1):110-5. PubMed ID: 2987290
[TBL] [Abstract][Full Text] [Related]
9. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
10. [Na K ATPase activity in mammalian erythrocytes].
Kazennov AM; Maslova MN; Shalabodov AD
Biokhimiia; 1984 Jul; 49(7):1089-95. PubMed ID: 6089915
[TBL] [Abstract][Full Text] [Related]
11. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on the relationship between erythrocyte ATPase activity and lipid peroxidation in essential hypertension].
Shi B
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Feb; 21(1):26-8, 63. PubMed ID: 8223150
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte sodium-potassium transport in cystic fibrosis.
Sigström L; Strandvik B
Pediatr Res; 1992 May; 31(5):425-7. PubMed ID: 1318537
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on assay for Na-K ATPase in human blood cells. I. Erythrocyte Na-K ATPase assay in patients with thyroid dysfunction and in those with chronic renal failure].
Ogasawara H; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):329-39. PubMed ID: 2842203
[TBL] [Abstract][Full Text] [Related]
15. [Effect of glycosphingolipids on erythrocyte Na+,K+-ATPase activity].
Sotskiĭ OP; Akopov SE; Sarkisova GM; Chukhadzhian GA
Ukr Biokhim Zh (1978); 1984; 56(6):642-6. PubMed ID: 6096995
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of lead and EDTA on Na+,K+-ATPase activity of erythrocyte membranes.
Karai I; Lee SI; Horiguchi S; Fukumoto K; Matsumura S; Takise S
J Toxicol Environ Health; 1983; 12(4-6):721-30. PubMed ID: 6321747
[TBL] [Abstract][Full Text] [Related]
17. Na+K+ATPase activity and ouabain binding sites in erythrocytes in hyperthyroidism before and after treatment.
De Riva C; Chen S; Virgili F; Frigato F
J Endocrinol Invest; 1992 May; 15(5):363-7. PubMed ID: 1324264
[TBL] [Abstract][Full Text] [Related]
18. An increase in the Na+/K+-ATPase activity of erythrocyte membranes in workers employed in a lead refining factory.
Karai I; Fukumoto K; Horiguchi S
Br J Ind Med; 1982 Aug; 39(3):290-4. PubMed ID: 6284196
[TBL] [Abstract][Full Text] [Related]
19. Measurement by bioluminescence technique of erythrocyte membrane Na+,K+-ATPase activity in hypertensive patients.
Lechi C; Corradini P; Polignano R; Bonadonna G; Delva P; Lechi A
Clin Chim Acta; 1987 Mar; 163(3):329-37. PubMed ID: 3034452
[TBL] [Abstract][Full Text] [Related]
20. Hypokalemia, high erythrocyte Na+ and low erythrocyte Na,K-ATPase in relatives of patients dying from sudden unexplained death syndrome in north-east Thailand and in survivors from near-fatal attacks.
Tosukhowong P; Chotigasatit C; Tungsanga K; Sriboonlue P; Pansin P; Sitprija V
Am J Nephrol; 1996; 16(5):369-74. PubMed ID: 8886172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
